Mukesh Batra

Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV.

Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.

Eurofins Advinus Ltd. engages in the provision of research and development services that supports the discovery and development of compounds for diverse industries. The firm's services include drug and agrochemical discovery and development, biologics testing, and REACH (Registration, Evaluation, and Authorization of Chemicals) support. It serves the pharmaceuticals, biologicals, agrochemicals, nutraceuticals, and cosmetics markets. The company was founded by Kasim A. Mookhtiar in 2005 and is headquartered in Bangalore, India.

Biocon Biologics India Ltd. operates as a biotech company. It develops treatments for chronicle diseases. The company is headquartered in Bengaluru, India.

Viatris Healthcare (Pty) Ltd. manufactures pharmaceuticals. its products include prescription generic, branded generic, brand-name drugs and over-the-counter remedies. The company was founded in 1961 and is headquartered in Johannesburg, South Africa.